By GuruFocus, Contributor We have just updated the portfolio of Ken Fisher. He buys Apple Inc, Basf SE, American Express Co, McDonald’s Corporation, Rio Tinto PLC, BP etc. As of 03/31/2013, Fisher Asset Management, LLC owns 483 stocks with a total value of $37.6 billion. These are the details of the buys and sells that have the impact to portfolio of more than .1%. New Purchases: CSTR, VSH, VALE.P, Added Positions: AAPL, BASFY, AXP, MCD, RIO, BP, CSCO, JPM, MTU, RHHBY, Reduced Positions: AMX, PBR, V, BIDU, EC, VALE, BRGYY, EAT, Sold Out: KMTUY, MW, For the details of Ken Fisher’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Ken+Fisher
Tag Archives: RIO
24/7 Wall St. Closing Bell — March 19, 2013: Market Closes Mixed Without Solution in Cyprus (JNPR, RIO, CHK, EBAY, EA, FF, SBLK, FDS, WAG, ADBE, CTAS, FTEK, WSM, FDX, GIS, LEN, AFFY, S, HAL, SLB)
Filed under: Investing
U.S. equity markets opened higher this morning but worries about a resolution to the banking crisis in Cyprus soon took over and pushed shares down. In other parts of Europe, Spain’s bad loan ratio rose to 10.78% in January and eurozone economic sentiment came in far below expectations. German 10-year bond yields fell on a rising dollar. In Asia, China’s central bank will drain 39 billion yuan in liquidity with a short-term repurchase agreement after foreign direct investment fell less than expected in the month. In the U.S., the report on housing starts was somewhat better than last month, with an annualized 917,000 new homes being built (more coverage here). The Cypriot parliament rejected a revised tax proposal on bank deposits (more coverage here), so it’s anyone’s guess what tomorrow may bring.
The U.S. dollar index rose 0.35% today, now at 82.983. The GSCI commodity index is down 0.3% at 650.30, with commodities prices mixed today. WTI crude oil closed down 1.7% today, at $92.16 a barrel. Brent crude trades down 1.8% at $107.50 a barrel. Natural gas is up 2.1% today at about $3.96 per million BTUs. Gold settled up 0.4% today at $1,611.30 an ounce.
The unofficial closing bells put the DJIA up about 4 points to 14,455.90 (0.03%), the NASDAQ fell more than 8 points (-0.26%) to 3,229.10, and the S&P 500 fell -0.24% or nearly 4 points to 1,548.35.
There were a several analyst upgrades and downgrades today, including Juniper Networks Inc. (NYSE: JNPR) cut to ‘sell’ at Goldman Sachs; Rio Tinto plc (NYSE: RIO) cut to ‘sell’ at Goldman Sachs; Chesapeake Energy Corp. (NYSE: CHK) cut to ‘underperform’ at Sterne Agee (more coverage here); eBay Inc. (NASDAQ: EBAY) raised to ‘buy’ with a price target of $56 at Cantor Fitzgerald; and Electronic Arts Inc. (NASDAQ: EA) cut to ‘hold’ at Needham.
Earnings reports since markets closed last night resulted in several price moves today, including these: FutureFuel Corp. (NYSE: FF) is down 9.2% at $12.40; Star Bulk Carriers Corp. (NASDAQ: SBLK) is up 5.7% at $6.50; FactSet Research Systems Inc. (NYSE: FDS) is down 5.6% at $92.52; and Walgreen Co. (NYSE: WAG) is up 5.2% at $44.65 (more coverage here).
Before markets open tomorrow morning we are scheduled to hear from Adobe Systems Inc. (NASDAQ: ADBE), Cintas Corp. (NASDAQ: CTAS), Fuel Tech Inc. (NASDAQ: FTEK), Williams-Sonoma Inc. (NYSE: WSM), FedEx Corp. (NYSE: FDX), General Mills Inc. (NYSE: GIS), and Lennar Corp. (NYSE: LEN).
Some standouts among heavily traded stocks today include:
Affymax Inc. (NASDAQ: AFFY) is down 62.6% at $1.09 after posting a new 52-week low of $1.02 earlier today. The drugmaker fired 75% of its workforce today and will begin exploring “strategic alternatives” including bankruptcy. More coverage here.
Sprint Nextel Corp. (NYSE: S) is up 2.9% at $6.05 after posting a new 52-week high of $6.09 earlier today. The telecom company had no big news today, but led a sector that was up on a down day.
Halliburton Co. (NYSE: HAL) is down 3.4% at $39.36. The oil field …read more
Source: FULL ARTICLE at DailyFinance
5 Stocks That Bears Are Avoiding
By Rick Aristotle, Munarriz, The Motley Fool
Filed under: Investing
Fear is never universal.
Yesterday I went over five stocks with short interests at 52-week highs. Today I’m going to look at the other end of the spectrum.
There are plenty of stocks where the worrywarts have been running for the hills. The five stocks that I’ll be going over here are either at or near their recent lows when it comes to the number of shares sold short.
Why are fewer investors betting against these companies? Every stock has a unique story to tell. For investors, there are two opposing ways to approach the data.
A bull will see it as validation. The market agrees with the sentiment. A bear can approach this list from the contrarian perspective. Unlike yesterday’s list of prime candidates for a short squeeze, there are apparently fewer skeptics to sway here.
Since the stock exchanges offer up short interest twice a month, giving us 24 snapshots a year, let’s look at the mid-February tallies that were provided late last week and compare them to the bearish wagers placed just six months earlier.
| Company |
Feb. 15, 2013 |
Aug. 15, 2012 |
|---|---|---|
|
Netflix |
8.1 million |
14.3 million |
|
|
25.4 million |
88.0 million |
|
MAKO Surgical |
11.4 million |
14.1 million |
|
Lennar |
32.8 million |
33.7 million |
|
SodaStream |
7.7 million |
8.9 million |
Source: Barron’s.
Feeding the bears
Netflix has seen its stock more than triple over the past six months, forcing a lot of bears to scramble and cover their short positions.
Cynics will argue that now is the best time to take a stance against the leading video service, but Netflix continues to grow its global audience and ink the content deals that make it difficult for anyone else to catch up.
Netflix now has more than 33 million streaming customers worldwide. The valuation is stiff, sure, but there doesn’t seem to be any chance to derail the niche leader after last month’s debut of House of Cards positions Netflix as a vastly cheaper yet far more thorough HBO.
Facebook was a widely lampooned IPO last year, and it wasn’t a surprise to see shorts balloon to 88 million three months after going public in May. Investors feared that the leading social networking website operator was going to suffer in the mobile migration. There were also reports of the site’s popularity waning.
Facebook blasted through the concerns. Active monthly users have gone on to top 1 billion, and new mobile monetization efforts are turning the growing engagement of Facebook on smartphones and tablets an opportunity instead of a challenge.
MAKO Surgical shorts are near its 52-week low of 11.3 million.
MAKO is the company behind the RIO surgical robotics platform that is used for orthopedic procedures. Unlike Netflix and Facebook, which have been rallying, MAKO shares are trading near their lows.
MAKO‘s stock took a hit after the company warned of a slowdown in orders for new RIO systems a few months ago. Last week’s updated outlook is cautious. MAKO sees itself selling less …read more
Source: FULL ARTICLE at DailyFinance
5 of Last Week's Biggest Winners
By Rick Aristotle Munarriz, The Motley Fool
Filed under: Investing
What’s better than momentum? Mo’ momentum. Let’s take a closer look at five of this past week’s biggest scorchers.
|
Company |
March 1 |
Weekly Gain |
|---|---|---|
|
MediciNova |
$2.98 |
47% |
|
MGIC Investment |
$3.79 |
39% |
|
MAKO Surgical |
$12.75 |
13% |
|
Ebix |
$15.33 |
11% |
|
Celldex Therapeutics |
$10.26 |
10% |
Source: Barron’s.
MediciNova was an obscure and thinly traded biotech until it received fast-track designation from the FDA for its potentially promising treatment of methamphetamine dependence on Monday afternoon. Fast-track status grants an expedited review of drugs that aim to fill an unmet medical niche or treat serious diseases. More than 6 million shares of MediciNova traded hands last week, and it’s safe to say that MediciNova will no longer be an obscure and thinly traded biotech.
MGIC soared despite posting its 10th consecutive quarterly loss on Thursday. The shares rallied on the market’s confidence that home prices in general will continue to firm, making MGIC’s dicey portfolio less risky.
MAKO Surgical also bounced back after posting uninspiring financial results. They key here is that the company behind the RIO surgical robotics system for orthopedic procedures had already braced investors for the soft showing back in January. The market was won over by its cautious outlook for the year ahead, calling for the sale of 45 to 48 new RIO systems and roughly 13,500 to 14,500 procedures for all of 2013.
Ebix bounced back after getting pounded a week earlier on a bearish report. The insurance industry software specialist rose after hosting a conference call to refute the negative claims in the report. Ebix was apparently convincing enough to gain back a good chunk of the prior week’s hit.
Celldex Therapeutics has now come through with three straight weeks featuring gains of 8% or better. Momentum continues to build after revealing positive test results for its treatment for hematopoietic stem cell transplantation last month.
Keep the good vibes coming
To learn more about a few ETFs that have great promise for delivering profits to shareholders in a recovering global economy, check out The Motley Fool’s special free report “3 ETFs Set to Soar During the Recovery.” Just click here to access it now.
The article 5 of Last Week’s Biggest Winners originally appeared on Fool.com.
Longtime Fool contributor Rick Aristotle Munarriz owns shares of Ebix. The Motley Fool recommends Ebix and MAKO Surgical and owns shares of Ebix. Try any of our Foolish newsletter services free for 30 days. We Fools don’t all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
…read more
Source: FULL ARTICLE at DailyFinance